Celgene's drug for anemia in beta thalassemia priced at $3,441/ 25 mg vial

Celgene Corp’s treatment for anemia in patients with beta thalassemia, a rare blood disorder, would be priced at $3,441 for a 25-milligram vial of the drug, partner Acceleron Pharma Inc said.


Source: Reuters Health

Be the first to comment

Leave a Reply

Your email address will not be published.


*